Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
LDE225 for Patients With PTCH1 or SMO Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
- Status
- COMPLETED
- Phase
- PHASE4
Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- PHASE2
STAR Cape+BKM120 MBC With Brain Met
- Status
- COMPLETED
- Phase
- PHASE2
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD.
- Status
- WITHDRAWN
- Phase
- PHASE4
24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Vascular Effects of Serelaxin
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE1
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
- Status
- COMPLETED
- Phase
- PHASE3
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)
- Status
- COMPLETED
- Phase
- PHASE4